Teladoc Health, Inc.·4

Mar 5, 4:10 PM ET

Verstraete Stephany 4

4 · Teladoc Health, Inc. · Filed Mar 5, 2024

Insider Transaction Report

Form 4
Period: 2024-03-01
Verstraete Stephany
Chief Marketing Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-01+4,43747,554 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+43747,991 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+86748,858 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+1,40450,262 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+13,02163,283 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+1,14864,431 total
  • Sale

    Common Stock

    2024-03-04$14.52/sh7,945$115,33056,486 total
  • Award

    Performance Stock Units

    2024-03-01+13,31313,313 total
    Common Stock (13,313 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-014,4378,876 total
    Common Stock (4,437 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-014370 total
    Common Stock (437 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-018670 total
    Common Stock (867 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-011,4045,616 total
    Common Stock (1,404 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-0113,02126,042 total
    Common Stock (13,021 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-011,1480 total
    Common Stock (1,148 underlying)
Footnotes (12)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F10]On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F11]On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F12]On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
  • [F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F7]On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F8]On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
  • [F9]On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

Documents

1 file
  • 4
    wk-form4_1709672996.xmlPrimary

    FORM 4